By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    What Are the Benefits of CBD?
    November 27, 2021
    How to Measure Adult Diapers- The Ultimate Guide to Picking the Right Size
    March 8, 2022
    medicine cabinet
    The Effect Of Finished Dosage Form Manufacturing In New Drugs
    July 5, 2022
    Latest News
    7 Most Common Healthcare Accreditation Programs: Which Should You Use?
    August 20, 2025
    Hospital Pest Control and the Fight Against Superbugs
    August 20, 2025
    Hygiene Beyond The Clinic: Attention To Overlooked Non-Clinical Spaces
    August 13, 2025
    5 Steps to a Promising Career as a Healthcare Administrator
    August 3, 2025
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    Ebola Education, Hospital Marketing, Healthcare Marketing, Healthcare Communication
    Hospital Marketing and Ebola: Communication and Education Needed
    October 30, 2014
    healthcare IT
    The Billion Dollar Healthcare IT Opportunity That the US Government Wasted
    January 27, 2013
    red bull
    Downing Energy Drinks: A Real Buzz Kill
    March 17, 2015
    Latest News
    How Social Security Disability Shapes Access to Care and Everyday Health
    August 22, 2025
    How a DUI Lawyer Can Help When Your Future Health Feels Uncertain
    August 22, 2025
    How One Fall Can Lead to a Long Road of Medical Complications
    August 22, 2025
    How IT and Marketing Teams Can Collaborate to Protect Patient Trust
    July 17, 2025
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Does Disclosure Work?
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Public Health > Does Disclosure Work?
BusinessNewsPublic Health

Does Disclosure Work?

gooznews
gooznews
Share
5 Min Read
SHARE

Thanks to Larry Husten and the Cardiobrief blog for reprinting Harlan Krumholz’ New England Journal of Medicine article calling attention to a series of studies that show sponsors of a huge number of clinical trials, including those financed by the National Institutes of Health, are not divulging their results. Krumholz concludes:

Thanks to Larry Husten and the Cardiobrief blog for reprinting Harlan Krumholz’ New England Journal of Medicine article calling attention to a series of studies that show sponsors of a huge number of clinical trials, including those financed by the National Institutes of Health, are not divulging their results. Krumholz concludes:

The absence of the data renders meta-analyses, systematic reviews, and book chapters suspect. Conclusions are made on the basis of incomplete science. In short, publication bias and selective publication are impugning the validity of what we can learn from a PubMed search or even the most careful review of published studies.

The studies, which first appeared in the British Medical Journal, include:

Ross et al: Despite recent improvement in timely publication, fewer than half of trials funded by NIH are published in a peer reviewed biomedical journal indexed by Medline within 30 months of trial completion. Moreover, after a median of 51 months after trial completion, a third of trials remained unpublished.

Hart et al: The effect of including unpublished FDA trial outcome data varies by drug and outcome.

Ahmed et al: Publication, availability, and selection biases are a potential concern for meta-analyses of individual participant data, but many reviewers neglect to examine or discuss them. These issues warn against uncritically viewing any meta-analysis that uses individual participant data as the most reliable.

Prayle et al: Most trials subject to mandatory reporting did not report results within a year of completion.

Wieland et al: Based on the results for 2005, at least 3000 records describing randomized controlled trials but not indexed using RCT may have been entered into Medline between 2006 and 2011.

The studies led by Ross and Prayle suggest that NIH-funded researchers are violating a law passed several years ago requiring publication of their results in a database. Did NIH fail to follow through on enforcing this requirement? Some enterprising reporter should investigate the possibility that investigators financed by the nation’s premier medical science research agency are violating this requirement wholesale.

More Read

Is pharma industry too meek on pricing?
Why Doctors Should Have Their Own Website
Free Market Prescription Drugs
How Wearables Will Transform the Health Insurance Game
California Insurers Slash Number of Doctors You Can See

This would appear to be one more example of where disclosure requirements, if unaccompanied by meaningful penalties, fail as a tool for policing bad behavior. In our age of hyper-commercialization and scientific competition, is sunlight still the best disinfectant, as Supreme Court Justice Louis Brandeis wrote in the early 20th century? Sometimes bleach works better. As Tracy Weber and Charles Ornstein of ProPublica reported yesterday, drug industry payments to physician “thought leaders” are slowing, not just because of greater disclosure, but because leading academic medical centers are cracking down on violators of their stricter policies limiting those payments.

The government cannot demand disclosure by investigators in privately-sponsored clinical trials. But NIH and the Food and Drug Administration, which receives data as part of new drug applications, can and should. If government-funded investigators fail to publish all their results in a timely manner — one year after the conclusion of a clinical trial seems reasonable — they should be barred from receiving new grants for at least three years. And companies that seek government approval for new drugs or expanded indications for old drugs should no longer be given the shield of “confidential business information” for any trial at the Phase II or III level, whether the drug or device is approved or not. Business matters, but public health and the accuracy of the science that informs it are more important.

TAGGED:clinical trialsNIH
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

engineer fitting prosthetic arm
How Social Security Disability Shapes Access to Care and Everyday Health
Health care
August 20, 2025
a woman explaining the document
How a DUI Lawyer Can Help When Your Future Health Feels Uncertain
Public Health
August 20, 2025
physiotherapist at work
How One Fall Can Lead to a Long Road of Medical Complications
Health care
August 20, 2025
Common Healthcare Accreditation Programs
7 Most Common Healthcare Accreditation Programs: Which Should You Use?
Health News
August 20, 2025

You Might also Like

Getting Value from Technology in Healthcare Is All about People

November 6, 2014
Stewart Schaffer BayCare Health
Business

BayCare Health: Delivering a Consumer-Driven Brand Experience [PODCAST]

October 10, 2014
Image
Public Health

Boomer Voice

June 12, 2013
Image
Health ReformNewsPolicy & LawWellness

Physician Burnout and the Changing Approach to Practice

February 14, 2013
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?